HCID 67003425, compound → HCID 67003591, compound
Reaction equation
[Cl:1][C:2]1[C:3]([C:24]2[S:28][C:27]([C:29]3([O:33]COC)[CH2:32][CH2:31][CH2:30]3)=[N:26][CH:25]=2)=[C:4]2[CH:10]=[C:9]([C:11]3[CH:16]=[CH:15][C:14]([O:17][CH2:18][CH:19]4[CH2:23][CH2:22][CH2:21][O:20]4)=[CH:13][CH:12]=3)[NH:8][C:5]2=[N:6][CH:7]=1.ClC1C(C2SC(C3(OCOC)CCC3)=NC=2)=C2C=C(C3N=C(C4CCCN(C(OC(C)(C)C)=O)C4)ON=3)NC2=NC=1>>[Cl:1][C:2]1[C:3]([C:24]2[S:28][C:27]([C:29]3([OH:33])[CH2:32][CH2:31][CH2:30]3)=[N:26][CH:25]=2)=[C:4]2[CH:10]=[C:9]([C:11]3[CH:16]=[CH:15][C:14]([O:17][CH2:18][CH:19]4[CH2:23][CH2:22][CH2:21][O:20]4)=[CH:13][CH:12]=3)[NH:8][C:5]2=[N:6][CH:7]=1Participants
3
Procedure
The title compound was prepared as described in Example 22E, substituting 5-(5-chloro-2-(4-((tetrahydrofuran-2-yl)methoxy)phenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-2-(1-(methoxymethoxy)cyclobutyl)thiazole (Example 70B) for 1 tert-butyl 3-(3-(5-chloro-4-(2-(1-(methoxymethoxy)cyclobutyl)thiazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-2-yl)-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate (Example 22D). 1H NMR (500 MHz, DMSO-d6) ppm 12.45 (s, 1H) 8.29 (s, 1H) 8.25 (s, 1H) 7.94 (d, 2H) 7.04 (d, 2H) 6.94 (d, 1H) 6.66 (s, 1H) 4.17 (m, 1H) 4.00 (m, 2H) 3.79 (m, 1H) 3.69 (m, 1H) 2.63 (m, 2H) 2.41 (m, 2H) 1.80-2.06 (m, 5H) 1.69 (m, 1H); MS ESI(+) m/z 482.0 [M+H]+.
Sources & evidence
- ORD record
- ord-73bee1428c794fc5a9771f9dc08f037e
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08691810B2
Reaction notes
Loading…